Fine Organic Industries Limited (NSE:FINEORG)
India · Delayed Price · Currency is INR | Market Cap | 156.29B +13.3% |
| Revenue (ttm) | 24.72B +7.1% |
| Net Income | 4.38B +5.7% |
| EPS | 142.90 +5.7% |
| Shares Out | 30.66M |
| PE Ratio | 35.69 |
| Forward PE | 33.24 |
| Dividend | 11.00 (0.22%) |
| Ex-Dividend Date | Jul 31, 2026 |
| Volume | 29,411 |
| Open | 5,124.00 |
| Previous Close | 5,124.00 |
| Day's Range | 4,985.50 - 5,124.00 |
| 52-Week Range | 3,856.00 - 5,666.00 |
| Beta | 0.25 |
| Analysts | Buy |
| Price Target | 5,392.27 (+5.73%) |
| Est. Earnings | Nov 6, 2026 |
About Fine Organic Industries
Fine Organic Industries Limited engages in manufacture, processing, supply, distribution, dealing, import, and export of oleochemical-based additives in India and internationally. The company offers food ingredient, such as emulsifiers, antifungal agents, bakery products, starch complexity agents, viscosity modifiers, anti-blooming agents, anti-splattering agents, crystal promoters, and anti-foam agents. It also provides polymer additives, including lubricants, anti-fogging additives, anti-slip agents, anti-static additives, anti-scratch additi... [Read more]
Financial Performance
In fiscal year 2026, Fine Organic Industries's revenue was 23.66 billion, an increase of 4.26% compared to the previous year's 22.69 billion. Earnings were 4.17 billion, an increase of 1.60%.
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for FINEORG stock is "Buy." The 12-month stock price target is ₹5,392, which is an increase of 5.73% from the latest price.
News
Top stocks: What are the top stock recommendations for October 15, 2026?
Top stock market recommendations: Lemon Tree Hotels, Greenply Industries, and Fine Organic Industries - Aakash K Hindocha, Vice President - Research, Nuvama Professional Clients Group/Nuvama Wealth ha...
Fine Organic Industries Quarterly report: Q1 2027
Fine Organic Industries has published its Q1 2027 quarterly earnings report on August 7, 2026.
Fine Organic Industries Slides: Q1 2027
Fine Organic Industries has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 7, 2026.
Fine Organic Industries Transcript: Q4 25/26
Revenue grew 4.3% and PAT rose 1.6% in FY 2026, with EBITDA margin at 20.4%. Expansion continues globally, but growth will remain flat until new SEZ and U.S. plants are commissioned in 2028, amid persistent raw material inflation and supply chain challenges.
Fine Organic Industries Quarterly report: Q4 2026
Fine Organic Industries has published its Q4 2026 quarterly earnings report on May 21, 2026.
Fine Organic Industries Slides: Q4 2026
Fine Organic Industries has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 21, 2026.
Fine Organic Industries Annual report: Q4 2026
Fine Organic Industries has published its Q4 2026 annual report on May 21, 2026.
Fine Organic Industries Quarterly report: Q3 2026
Fine Organic Industries has published its Q3 2026 quarterly earnings report on February 12, 2026.
Fine Organic Industries Slides: Q3 2026
Fine Organic Industries has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 12, 2026.
Fine Organic Industries Quarterly report: Q2 2026
Fine Organic Industries has published its Q2 2026 quarterly earnings report on November 7, 2025.
Fine Organic Industries Slides: Q2 2026
Fine Organic Industries has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 7, 2025.
Fine Organic Industries Q3 FY25 results: Net profit rises 30.5% YoY to Rs 82.69 crore, revenue jumps 5.1%
The company’s total revenue grew by 5.1% YoY, reaching ₹542.28 crore, up from ₹505.84 crore in the same quarter last year.
Fine Organic Industries to resume operations post-fire incident at Maharashtra plant
In a statement released to the stock exchanges, the company confirmed that it has made significant progress in restoring the plant’s operations to full capacity. The resumption marks a critical milest...